You might get the attention by telling them that if there ever was a challenge in care of treatment (such as adm of NTG in right side AMI) they might be held neglible for not performing a thourough assessment. That it is considered a standard in prehospital care for the past decade.
I would ask if their would be able to rationalize NOT performing in lieu of litigation. As well, why has your medical director has not enforced this yet?
Here are are some more article:
http://content.onlinejacc.org/cgi/content/full/j.jacc.2005.08.072v1
http://www.regionalpci-stemi.org/sitebuildercontent/sitebuilderfiles/nhaap-p12ekg.pdf
Pre-Hospital 12-Lead Electrocardiography Programs
A Call for Implementation by Emergency Medical Services Systems Providing Advanced Life Support—National Heart Attack Alert Program (NHAAP) Coordinating Committee; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health
J. Lee Garvey
Heart Disease and Stroke Statistics--2004 Update. American Heart Association.
2. National Heart Attack Alert Program Coordinating Committee. 60 minutes to
treatment working group. Emergency department: rapid identification and treatment
of patients with acute myocardial infarction. Ann Emerg Med. 1994; 23:311-329.
3. Yusuf S, Collins R, Peto R. et al. Intravenous and intracoronary fibrinolytic therapy
in acute myocardial infarction: Overview of results on mortality, reinfarction and
side effects from 33 randomized controlled trials. European Heart Journal
1985;6:556.
4. Cucherat M, Bonnefoy E, Tremeau G. Primary angioplasty versus intravenous
thrombolysis for acute myocardial infarction (Cochrane Review). The Cochrane
Library, Issue 1, 2004. Chichester, UK: John Wiley and Sons, Ltd.
5. DeLuca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment
and mortality in primary angioplasty for acute myocardial infarction: every minute
of delay counts. Circulation 2004;109:1223-1225.
6. Armstrong PW, Collen D, Antman E. Fibrinolysis for Acute Myocardial Infarction.
The future is here and now. Circulation 2003;107:2533-2537.
7. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in
acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-
775.
8. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for
fibrinolytic therapy in suspected acute myocardial infarction: collaborative
overview of early mortality and major morbidity results from all randomized trials
of more than 1000 patients. Lancet 1994;343:311-322.
9. Personal communication, Ms. Edna Stoehr, National Registry of Myocardial
Infarction.
10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman
JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL,
Sloan MA, Smith SC Jr. ACC/AHA guidelines for the management of patients
with ST-elevation myocardial infarction: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines
(Committee to Revise the 1999 Guidelines for the Management of Patients with
Acute Myocardial Infarction). 2004. Available at
http://www.acc.org/clinical/guidelines/stemi/index.pdf. [Executive Summary print
version published in the J Am Coll Cardiol, August 4, 2004 issue, or Circulation,
August 3, 2004.]
September 1, 2004—Preliminary Draft for the NHAAP Coordinating Committee
9
11. Dracup K, Moser DK,
Prehospital 12-lead ECG diagnostic programs
Emergency Medicine Clinics of North America - Volume 20, Issue 4 (November 2002) - Copyright © 2002 W. B. Saunders Company